Skip to content

Translation and validation of the Sleep Apnea Quality of Live Index (SAQLI) for the German-speaking population

Translation and validation of the Sleep Apnea Quality of Live Index (SAQLI) for the German-speaking population

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00033201
Enrollment
130
Registered
2023-12-21
Start date
2023-12-05
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G47.3

Interventions

Group 1: Experimental group: Patients with sleep apnea diagnosed by a polysomnography which complete the SAQLI, the Short form 36 (SF-36), the Functional Outcome of Sleep Questionnaire (FOSQ), the Ep

Sponsors

Siloah St. Trudpert Klinikum Pforzheim, Klinik für Hals-Nasen-Ohrenheilkunde
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Presence of a sleep apnea defined by the criteria of the American Association of Sleep Medicine (AASM) and the Deutschen Gesellschaft für Schlafmedizin (DGSM) - Decision for a therapy by the means of an CPAP or APAP - Sufficient knowledge of German to answer all questionnaires without any comprehension Problem or the need of help - Age of majority and capacity to consent

Exclusion criteria

Exclusion criteria: - Disagreement with the study or therapy - CPAP/APAP usage of less then 300 hours in the first three month (noncompliance) - Circumstances or recents diagnoses that stand not in connection with sleep apnea and have a strong impact on the live quality e.g. Diagnosis of a cancer or psychiatric disease

Design outcomes

Primary

MeasureTime frame
Aim of the study is, to compare our data in respect of the internal consistency, reliability, validity, responsiveness and sensitivity to those data of other studies which previously successfully translated and validated the SAQLI in an other language and of the original approval study of the SAQLI. If this comparison shows sufficient comparability, our aim of validating the SAQLI for the German speaking population would be reached.

Secondary

MeasureTime frame
Validation of our visual analogue scale for the assessment of the live quality of patient suffering from sleep-breathing disorders

Countries

Germany

Contacts

Public ContactMartin Sailer

Siloah St. Trudpert Klinikum Pforzheim, Klinik für Hals-Nasen-Ohrenheilkunde

martin.sailer@siloah.de+49 178 8092113

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026